Long COVID Research Accelerates
An estimated 65 million people worldwide experience long COVID symptoms. Research has identified several potential mechanisms: viral persistence, immune system dysregulation, blood vessel damage, and autoimmune responses. Clinical trials are testing antivirals, anti-inflammatory drugs, and rehabilitation protocols. The condition has reshaped disability policy, with many countries recognizing long COVID as a qualifying condition for workplace accommodations and social support.